AXGT - Axovant Gene Therapies EPS beats by $0.25 August, 11 2020 07:13 AM Axovant Gene Therapies Ltd. Axovant Gene Therapies (NASDAQ:AXGT): Q2 GAAP EPS of -$0.20 beats by $0.25.Cash and cash equivalents of $55.5M.Press ReleaseMore news on: Axovant Gene Therapies Ltd., Earnings news and commentary, ,